Clinical trial
HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent…
NCT00442962 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other · Completed
Key facts
| NCT number | NCT00442962 |
|---|---|
| Title | HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV |
| Official title | The Effect of Prior Short Course Combination Antiretroviral Therapy Administered for the Prevention of Mother-to-Child Transmission (pMTCT) of HIV-1 on Subsequent Treatment Efficacy in Treatment-"Nearly Naive" Participants |
| Acronym | Nearly Naive |
| Lead sponsor | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Efavirenz, Emtricitabine/Tenofovir disoproxil fumarate |
| Enrollment | 54 |
| Start date | May 1, 2007 |
| Primary completion | Jul 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Mar 5, 2007 |
| Last update posted | Oct 12, 2018 |
| Countries | Brazil, Peru, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: